Targeting cAMP in chronic lymphocytic leukemia: a pathway-dependent approach for the treatment of leukemia and lymphoma

By Murray Fiona   Insel Paul A  

Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 8, 2013-08 ,pp. : 937-949

Informa Healthcare

Access to resources Recommend Favorite

Patterns of c-fos expression induced by fluvoxamine are different after acute vs. chronic oral administration

By Veening J.G.   Coolen L.M.   Spooren W.J.P.M.   Joosten H.   van Oorschot R.   Mos J.   Ronken E.   Olivier B.  

European Neuropsychopharmacology, Vol. 8, Iss. 3, 1998-08 ,pp. : 213-226

Elsevier

Access to resources Recommend Favorite

Changes in the Temperament and Character Inventory dimensions after paroxetine treatment in patients with major depressive disorder

By  

Human Psychopharmacology: Clinical And Experimental (Electronic), Vol. 30, Iss. 5, 2015-09 ,pp. : 334-340

John Wiley & Sons Inc

Access to resources Recommend Favorite

Contrasting actions of acute or chronic paroxetine and fluvoxamine on morphine withdrawal-induced place conditioning

By Rafieian-Kopaei M.   Gray A.M.   Spencer P.S.J.   Sewell R.D.E.  

European Journal of Pharmacology, Vol. 275, Iss. 2, 1995-03 ,pp. : 185-189

Elsevier

Access to resources Recommend Favorite

Brain neurosteroid changes after paroxetine administration in mice

By Nechmad A.   Maayan R.   Spivak B.   Ramadan E.   Poyurovsky M.   Weizman A.  

European Neuropsychopharmacology, Vol. 13, Iss. 5, 2003-10 ,pp. : 327-332

Elsevier

Access to resources Recommend Favorite